Singapore markets closed

Straits Times Index
3,292.69
+10.64(+0.32%)
S&P 500
5,116.17
+16.21(+0.32%)
Dow
38,386.09
+146.43(+0.38%)
Nasdaq
15,983.08
+55.18(+0.35%)
Bitcoin USD
62,955.66
-677.18(-1.06%)
CMC Crypto 200
1,284.75
-54.32(-4.06%)

ABT Sep 2024 165.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 01:45PM EDT. Market open.

PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
Zacks
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Simply Wall St.
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation
Key Insights Abbott Laboratories to hold its Annual General Meeting on 26th of April Total pay for CEO Robert Ford...